The FDA has granted Medtronic’s Verify Evaluation System approval for three- to seven-day basic evaluations designed to expedite the potential for long-term restoration of bowel or bladder function, according to a Med Device Online report.
EndoChoice shares dropped 7.61 percent during the past week and decreased by 23.9 percent in the last four weeks, according to a News Watch International report.
Olympus released a new version of its SONICBEAT surgical device, which will enhance the entire Olympus THUNDERBEAT portfolio.
Lumicell, a company focused on image-guided cancer surgery, received approval from the FDA to launch a feasibility study in gastrointestinal cancers.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Anuja Vaidya at avaidya@beckershealthcare.com.
More GI/endoscopy news:
GI physician leader to know: Dr. David Forcione of Massachusetts General Hospital
Dr. H. Whitney Jennings joins Harbin Clinic: 4 quick facts
Leading medical journal publishes results on IBSREST study — 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.